Antisoma (ASM)
Summary
Sector: Pharmaceuticals & Biotechnology
Indices: FTSE All-Share | techMARK | techMARK 100 | FTSE Fledgling
Currency: UK Pounds
| Bid Price: | 5.65p | Volume: | 218,449 |
| Mid Price: | 5.65p | Market Cap: | 35.60m |
| Offer Price: | 5.89p | 52 Wk High/Low: | 37.75p / 4.94p |
| Prev Close Price: | 5.95p | Shares in Issue: | 630m |
| Change Today: |  -0.3p (-5.04%) | Updated: | 16:50 |
Antisoma: Company Overview
There is no company overview available for Antisoma.
Latest Announcements from Antisoma
| 27/08/2010 | 16:40 | Second Price Monitoring Extn |
| 27/08/2010 | 16:35 | Price Monitoring Extension |
| 26/08/2010 | 16:40 | Second Price Monitoring Extn |
| 26/08/2010 | 16:35 | Price Monitoring Extension |
| 19/08/2010 | 16:40 | Second Price Monitoring Extn |
Latest News featuring Antisoma
| 10/06/2010 | 15:12 | TechMARK movers: iPad boost for chip makers |
| 07/06/2010 | 15:11 | TechMARK movers: Broker sparks further recovery in |
| 04/06/2010 | 14:40 | TechMARK movers: PuriCore continues to fall |
| 03/06/2010 | 16:59 | London close: Footsie makes good gains |
| 03/06/2010 | 15:46 | TechMARK movers: 'Fast Track' for Antisoma drug |
Latest Antisoma Trades
| Date | Time | Buy/Sell | Price | Volume | Type (key) |
| 07/09/2010 | 16:35:04 | Sell | 5.70p | 38283 | Uncrossing Trade |
| 07/09/2010 | 15:55:11 | Sell | 5.65p | 4540 | Automatic Trade |
| 07/09/2010 | 15:15:06 | Sell | 5.71p | 10666 | Ordinary Trade |
| 07/09/2010 | 12:03:09 | Buy | 5.91p | 50752 | Ordinary Trade |
| 07/09/2010 | 11:42:36 | Buy | 5.91p | 4000 | Ordinary Trade |
| 07/09/2010 | 11:34:07 | Sell | 5.65p | 1513 | Automatic Trade |
Latest Antisoma Director Dealings
| Date | Notifier | Buy/Sell | Price | Volume |
| 06/04/2010 | Michael Lewis (Non-Executive Director) | Click For Details >> | ||
| 06/04/2010 | Barry J Price (Chairman) | Click For Details >> | ||
| 06/04/2010 | Birgit Stattin-Norinder (Non-Executive Director) | Click For Details >> | ||
| 06/04/2010 | Michael Lewis (Non-Executive Director) | Click For Details >> | ||
| 18/11/2009 | Barry J Price (Chairman) | Click For Details >> | ||
Antisoma Financial Overview
| Year End : | 30 June 2010 |
| Turnover : | £20m |
| Profit / Loss : | -£23m |
Antisoma Key Personnel & Dates
| CEO: | Glyn Edwards |
| Chairman: | Barry J Price |
| CFO: | Eric Dodd |
| Final Results: | n/a |
| Int. Results: | 18 February 2010 |
| AGM: | 16 November 2010 |
All data suppied by Digital Look (15 minute delay)
There is an extra risk of losing money when shares are bought in some smaller companies including 'Penny Shares'. There is a big difference between the buying price and the selling price of these shares. If they have to be sold immediately, you may get back much less than you paid for them or you may have difficulty in selling them. Past performance is not a reliable indicator of future results. The price may change quickly and it may go down as well as up. You could lose every penny put into a particular share.
The information contained above has been compiled from documented sources which are believed to be reliable but, due to their very nature, are subject to a degree of historical inaccuracy and have not been independently verified and cannot be guaranteed. The pages on this website are provided for information only. City Equities Limited will not accept responsibility for loss incurred by any person or body acting, or refraining from acting, as a result of information and/or opinions given anywhere on this website. Issued by City Equities Limited, Aldermary House, 10-15 Queen Street, London, EC4N 1TY. Registered in England. Registered No. 2742847. Registered Address: Amwell House, 19 Amwell Street, Hoddesdon, Herts. EN11 8TS. City Equities Limited is Authorised and regulated by the Financial Services Authority. Registration No. 155051.
